A multimodal fusion system predicting survival benefits of immune checkpoint inhibitors in unresectable hepatocellular carcinoma

Abstract Early identification of unresectable hepatocellular carcinoma (HCC) patients who may benefit from immune checkpoint inhibitors (ICIs) is crucial for optimizing outcomes. Here, we developed a multimodal fusion (MMF) system integrating CT-derived deep learning features and clinical data to pr...

Full description

Bibliographic Details

Published in:	npj Precision Oncology
Main Authors:	Jun Xu, Tengfei Wang, Junjun Li, Yong Wang, Zhangxiang Zhu, Xiao Fu, Junjie Wang, Zhenglin Zhang, Wei Cai, Ruipeng Song, Changlong Hou, Li-Zhuang Yang, Hongzhi Wang, Stephen T. C. Wong, Hai Li
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-06-01
Online Access:	https://doi.org/10.1038/s41698-025-00979-6